Rhythm Pharmaceuticals, Inc. (RYTM)
107.17
-5.36
(-4.76%)
USD |
NASDAQ |
Aug 28, 16:00
107.27
+0.10
(+0.09%)
After-Hours: 20:00
Rhythm Pharmaceuticals 30-Day Average Daily Volume : 621881.7 for Aug. 28, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 28, 2026 | 621881.7 |
| August 27, 2026 | 632951.5 |
| August 26, 2026 | 643106.9 |
| August 25, 2026 | 644620.3 |
| August 24, 2026 | 658118.6 |
| August 21, 2026 | 658792.9 |
| August 20, 2026 | 658226.6 |
| August 19, 2026 | 658809.0 |
| August 18, 2026 | 661912.7 |
| August 17, 2026 | 680296.0 |
| August 14, 2026 | 688982.2 |
| August 13, 2026 | 709654.4 |
| August 12, 2026 | 717634.3 |
| August 11, 2026 | 731515.1 |
| August 10, 2026 | 734830.9 |
| August 07, 2026 | 799023.9 |
| August 06, 2026 | 799619.7 |
| August 05, 2026 | 810244.2 |
| August 04, 2026 | 816976.7 |
| August 03, 2026 | 806179.7 |
| July 31, 2026 | 826001.4 |
| July 30, 2026 | 868323.2 |
| July 29, 2026 | 870831.6 |
| July 28, 2026 | 929410.4 |
| July 27, 2026 | 909644.1 |
| Date | Value |
|---|---|
| July 24, 2026 | 908189.7 |
| July 23, 2026 | 921020.7 |
| July 22, 2026 | 926215.7 |
| July 21, 2026 | 928714.1 |
| July 20, 2026 | 926233.6 |
| July 17, 2026 | 923781.0 |
| July 16, 2026 | 911875.0 |
| July 15, 2026 | 909217.2 |
| July 14, 2026 | 911346.0 |
| July 13, 2026 | 911362.6 |
| July 10, 2026 | 915637.1 |
| July 09, 2026 | 915288.4 |
| July 08, 2026 | 906508.9 |
| July 07, 2026 | 897044.4 |
| July 06, 2026 | 881743.3 |
| July 02, 2026 | 875880.1 |
| July 01, 2026 | 861639.8 |
| June 30, 2026 | 851490.0 |
| June 29, 2026 | 837689.7 |
| June 26, 2026 | 838165.8 |
| June 25, 2026 | 788223.4 |
| June 24, 2026 | 787049.3 |
| June 23, 2026 | 784903.9 |
| June 22, 2026 | 771354.9 |
| June 18, 2026 | 754640.4 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.636M |
| Alnylam Pharmaceuticals, Inc. | 2.050M |
| BioMarin Pharmaceutical, Inc. | 2.090M |
| Cytokinetics, Inc. | 1.834M |
| Exelixis, Inc. | 2.456M |